SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3e0g'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DVX_B_DIFB125_1
(TRANSTHYRETIN)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 7 ALA A 444
LEU A 442
SER A 440
SER A 401
None
0.86A 1dvxA-3e0gA:
undetectable
1dvxA-3e0gA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DVX_B_DIFB125_1
(TRANSTHYRETIN)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 7 LEU A 320
LEU A 359
SER A 368
SER A 370
None
0.80A 1dvxA-3e0gA:
undetectable
1dvxA-3e0gA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V8B_C_ADNC2502_2
(ADENOSYLHOMOCYSTEINA
SE)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
3 / 3 GLU A 463
THR A 464
LEU A 295
NAG  A 489 (-4.2A)
None
None
0.64A 1v8bC-3e0gA:
undetectable
1v8bC-3e0gA:
23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PRG_A_BRLA1_2
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
3 / 3 ILE A 250
ILE A 210
LEU A 241
None
0.54A 2prgA-3e0gA:
undetectable
2prgA-3e0gA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPB_D_SAMD1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
5 / 10 THR A 261
VAL A 209
ILE A 210
ILE A 253
SER A 254
None
None
None
None
FUC  A 492 ( 3.8A)
1.27A 3kpbD-3e0gA:
undetectable
3kpbD-3e0gA:
13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACA_C_DXCC1475_0
(TRANSLATION
ELONGATION FACTOR
SELB)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 8 ILE A 216
ASP A 215
ILE A 253
GLY A 279
None
0.77A 4acaC-3e0gA:
undetectable
4acaC-3e0gA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACB_C_DXCC1475_0
(TRANSLATION
ELONGATION FACTOR
SELB)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 8 ILE A 216
ASP A 215
ILE A 253
GLY A 279
None
0.81A 4acbC-3e0gA:
undetectable
4acbC-3e0gA:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAT_A_BEZA1000_0
(BENZOATE-COENZYME A
LIGASE)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 7 ALA A 278
GLY A 279
GLY A 213
ILE A 253
None
0.65A 4eatA-3e0gA:
undetectable
4eatA-3e0gA:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IK7_B_IMNB201_1
(TRANSTHYRETIN)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 8 THR A 358
SER A 317
THR A 319
VAL A 321
NAG  A 484 (-3.0A)
None
None
None
0.40A 4ik7B-3e0gA:
undetectable
4ik7B-3e0gA:
13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_A_STRA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
5 / 12 ALA A  95
ILE A 123
ILE A 193
VAL A 167
VAL A 125
None
0.94A 4nkxA-3e0gA:
undetectable
4nkxA-3e0gA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWW_A_ACAA18_2
(SCRFP-TAG,GP41)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
3 / 3 LYS A 470
TRP A 471
SER A 469
None
1.17A 5nwwA-3e0gA:
undetectable
5nwwA-3e0gA:
7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X2T_I_PEMI202_1
(HEMOGLOBIN SUBUNIT
ALPHA
HEMOGLOBIN SUBUNIT
BETA)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
4 / 8 PRO A 205
ALA A 247
THR A 217
ALA A 155
None
0.95A 5x2tI-3e0gA:
undetectable
5x2tJ-3e0gA:
undetectable
5x2tK-3e0gA:
undetectable
5x2tL-3e0gA:
undetectable
5x2tI-3e0gA:
14.85
5x2tJ-3e0gA:
18.89
5x2tK-3e0gA:
14.85
5x2tL-3e0gA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BZO_C_FI8C1201_0
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)
3e0g LEUKEMIA INHIBITORY
FACTOR RECEPTOR

(Homo
sapiens)
5 / 12 THR A 261
VAL A 275
VAL A 263
SER A 258
VAL A 311
None
1.40A 6bzoC-3e0gA:
undetectable
6bzoC-3e0gA:
16.71